People: Intra-Cellular Therapies Inc (ITCI.OQ)
ITCI.OQ on NASDAQ Stock Exchange Global Select Market
13.97USD
15 Feb 2019
13.97USD
15 Feb 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$13.97
$13.97
Open
$13.74
$13.74
Day's High
$13.98
$13.98
Day's Low
$13.57
$13.57
Volume
101,360
101,360
Avg. Vol
132,873
132,873
52-wk High
$25.74
$25.74
52-wk Low
$10.24
$10.24
Halstead, Michael
Mr. Michael I. Halstead is the Senior Vice President, General Counsel, Secretary of Intra-Cellular Therapies, Inc. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporate Development at Warner Chilcott where he directed the company’s corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk & Wardwell. Mr. Halstead received his bachelor’s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.
Basic Compensation
Total Annual Compensation, USD | 683,000 |
Restricted Stock Award, USD | 966,961 |
Long-Term Incentive Plans, USD | -- |
All Other, USD | 766,316 |
Fiscal Year Total, USD | 2,416,280 |
Options Compensation
Quantity | Market Value | |
---|---|---|
Exercisable | -- | -- |
Unexercisable | -- | -- |
Exercised | -- | -- |
Name | Fiscal Year Total |
---|---|
Lawrence Hineline |
2,351,950 |
Mark Neumann |
-- |
Andrew Satlin |
2,018,330 |
Robert Davis |
2,008,300 |
Michael Halstead |
2,416,280 |
Suresh Durgam |
-- |
As Of
31 Dec 2017